Osteopore (ASX:OSX) has announced its entered into a binding asset purchase deed to acquire multiple medical distribution businesses that are currently responsible for approximately 40%-45% of Osteopore’s total sales globally.

Osteopore says the acquisition will transition the company towards a vertically integrated business, controlling the entire process from manufacturing and marketing, through to direct retail sales, and is expected to result in greater revenue and increased margins.

It says the consideration for the acquisition is no cash upfront, subject to the offsetting of debtor balances, and performance rights subject to achieving performance milestones.

Osteopore will also engage the Vendor as a contractor and is currently investigating additional potential acquisitions and partnership opportunities.